Carnegie Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$27.3M |
| 2 |
TSMC
TSM
|
+$22.5M |
| 3 |
Chubb
CB
|
+$10.3M |
| 4 |
Synopsys
SNPS
|
+$7.01M |
| 5 |
TE Connectivity
TEL
|
+$4.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$45.2M |
| 2 |
Credo Technology Group
CRDO
|
+$28.6M |
| 3 |
Reddit
RDDT
|
+$24.9M |
| 4 |
Applied Materials
AMAT
|
+$24.9M |
| 5 |
Zoetis
ZTS
|
+$24.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.54% |
| 2 | Financials | 15.25% |
| 3 | Industrials | 11.19% |
| 4 | Communication Services | 8.16% |
| 5 | Consumer Discretionary | 7.58% |
Similar funds
Carnegie Investment Counsel's Q2 2026 Portfolio in Review
As of Q2 2026, Carnegie Investment Counsel held 591 positions worth $4.99B, down 2.7% from $5.13B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Carnegie Investment Counsel withdrew a net $651M in Q2 2026, closing 44 positions and reducing 325 holdings. Its most notable exit was GRAIL Inc, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
Against the trend, Carnegie Investment Counsel opened a new position in Molson Coors Class B worth $3.12M.
- Carnegie Investment Counsel's largest Q2 2026 buy was Molson Coors Class B: 80,042 shares worth $3.12M.
- Carnegie Investment Counsel added most to Procter & Gamble in Q2 2026, an estimated $27.3M increase.
- Carnegie Investment Counsel's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $45.2M.
- Carnegie Investment Counsel fully exited GRAIL Inc in Q2 2026, selling an estimated $11.2M.
- Carnegie Investment Counsel's ten largest holdings make up 25% of its $4.99B portfolio in Q2 2026.
- Carnegie Investment Counsel opened 32 new positions and closed 44 in Q2 2026.
- Carnegie Investment Counsel's portfolio value fell 2.7% quarter-over-quarter to $4.99B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.